Study on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma: Not a Case-Control Study Reply JAMA DERMATOLOGY Li, S., Chang, A. S. 2016; 152 (10): 1173

View details for PubMedID 27732729